PTH and renal osteodystrophy: As a disturbed phosphate metabolism and abnormal parathyroid hormone (PTH) levels, either low or high, contribute to vascular calcification and renal osteodystrophy, the effect of different phosphate binding agents need to be evaluated on both pathologies.